Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

 

 

 

MODERATOR:

Dean Kereiakes, MD

Dean Kereiakes, MD
Medical Director, The Christ Hospital Research Institute 
Professor of Clinical Medicine
The Ohio State University
Cincinnati, OH

 

PANEL:

Orcherstra Biomed Panel


AGENDA:
 

  • Challenges of ISR Treatment & DES vs. DCB Trials
    Dean Kereiakes, MD
     
  • Potential Hazards of Re-Stenting 
    David Kandzari, MD 
     
  • All DCBs Are Not Created Equal
    James Zidar, MD
     
  • Virtue® Sirolimus-Eluting Balloon
    Juan Granada, MD

 

 

   Sponsored by:

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention